| Literature DB >> 30249786 |
Lorenz Thurner1, Klaus-Dieter Preuss1, Moritz Bewarder1, Maria Kemele1, Natalie Fadle1, Evi Regitz1, Sarah Altmeyer1, Claudia Schormann1, Viola Poeschel1, Marita Ziepert2, Silke Walter3, Patrick Roth4, Michael Weller4, Monika Szczepanowski5, Wolfram Klapper5, Camelia Monoranu6, Andreas Rosenwald6, Peter Möller7, Sylvia Hartmann8,9, Martin-Leo Hansmann8,9, Andreas Mackensen10, Henning Schäfer11, Elisabeth Schorb11, Gerald Illerhaus12, Rolf Buslei13, Rainer Maria Bohle14, Stephan Stilgenbauer1, Yoo-Jin Kim14, Michael Pfreundschuh1.
Abstract
To address the role of chronic antigenic stimulation in primary central nervous system lymphoma (PCNSL), we searched for autoantigens and identified sterile α-motif domain containing protein 14 (SAMD14) and neural tissue-specific F-actin binding protein I (neurabin-I) as autoantigenic targets of the B-cell receptors (BCRs) from 8/12 PCNSLs. In the respective cases, SAMD14 and neurabin-I were atypically hyper-N-glycosylated (SAMD14 at ASN339 and neurabin-I at ASN1277), explaining their autoimmunogenicity. SAMD14 and neurabin-I induced BCR pathway activation and proliferation of aggressive lymphoma cell lines transfected with SAMD14- and neurabin-I-reactive BCRs. Moreover, the BCR binding epitope of neurabin-I conjugated to truncated Pseudomonas exotoxin-killed lymphoma cells expressing the respective BCRs. These results support the role of chronic antigenic stimulation by posttranslationally modified central nervous system (CNS) driver autoantigens in the pathogenesis of PCNSL, serve as an explanation for their CNS tropism, and provide the basis for a novel specific treatment approach.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30249786 DOI: 10.1182/blood-2018-03-836932
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113